Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (6): 897-900    DOI: 10.12891/ceog4355.2018
Original Research Previous articles | Next articles
Decreased plasma concentrations of pregnancy-associated placenta-specific microRNAs in pregnancies with a diagnosis of fetal trisomy 18
K. Miura1, *(), A. Higashijima1, Y. Hasegawa1, S. Miura1, A. Yoshida1, H. Masuzaki1
1 Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objectives: This study aimed to clarify the association between circulating pregnancy-associated, placenta-specific microRNAs in the maternal plasma of women with fetal trisomy 18 pregnancies. Materials and Methods: All samples were obtained after receiving written informed consent and the study protocol was approved by the Institutional Review Board. Maternal blood samples (7 ml) were obtained at 16–19 weeks of gestation from 13 pregnant women carrying fetuses with trisomy 18 (trisomy 18 pregnancy group) and from 24 pregnant women carrying fetuses with normal karyotypes (normal karyotype pregnancy group). The plasma concentrations of pregnancy- associated, placenta-specific microRNAs (miR-515-3p, -517a, -517c, and -518b) were measured by quantitative RT-PCR. Results: No significant differences in clinical characteristics were observed between the two groups. miR-515-3p, miR-517a, miR-517c, and miR- 518b were shown to be present in significantly lower plasma concentrations in the trisomy 18 pregnancy group than in the normal karyotype pregnancy group. Plasma concentrations of cell-free miR-517c could distinguish pregnancies with fetal trisomy 18 from those with normal fetal karyotypes, yielding an area under the curve of 0.733 (95% confidence interval: 0.559–0.881). Conclusion: Cell-free pregnancy- associated, placenta-specific microRNAs may therefore be potential molecular markers to estimate the risk of pregnancies with fetal trisomy 18.
Key words:  Placenta-specific microRNA      Pregnancy      Fetal trisomy 18      Maternal plasma      Molecular marker     
Published:  10 December 2018     
*Corresponding Author(s):  K. MIURA     E-mail:  kiyonori@nagasaki-u.ac.jp

Cite this article: 

K. Miura, A. Higashijima, Y. Hasegawa, S. Miura, A. Yoshida, H. Masuzaki. Decreased plasma concentrations of pregnancy-associated placenta-specific microRNAs in pregnancies with a diagnosis of fetal trisomy 18. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 897-900.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4355.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I6/897

[1] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[2] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[3] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[4] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[5] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[6] Z.Y. Chang, R. Cao, R.C. Xu, Y. Cheng, Q.J. Wan. Pregnancy in a peritoneal dialysis patient undergoing intermittent peritoneal dialysis during the third trimester of pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 596-599.
[7] C.Y. Huang, T.C. Chao, H.C. Chien, Y.L. Liu. Outcome of shared decision-making in a patient with primary herpes gingivostomatitis during pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 604-606.
[8] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[9] K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku. Anti-E alloimmunization in a pregnancy with a low antibody titer[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 614-616.
[10] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[11] G. Keren, G. Ayala. Factors associated with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 391-395.
[12] H. Cokmez, C. Bayram. Pituitary apoplexy developing during pregnancy: escape from the verge of death[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 429-431.
[13] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[14] Y.Q. Xu, X. L. Chen, S. Zhao, P. W. Chen, X. M. Yin, S. Y. Xiong, Z. Ding, F. Xiong, X. H. Yang. OEIS complex (omphalocele-exstrophy-imperforate anus-spinal defects) in monozygotic twins: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 154-158.
[15] H.F. Zhang, J. Zhang, D. Yang, S.N. Li. Clinical analysis of atrial fibrillation in pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 174-178.
No Suggested Reading articles found!